🇺🇸 FDA
Patent

US 9518080

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

granted A61PA61P25/00A61P25/02

Quick answer

US patent 9518080 (Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P25/00, A61P25/02, A61P25/08, A61P25/22